Investing.com - Financial Markets Worldwide

BetterLife Pharma Inc (BETR)

CSE
Symbol
Exchange
Currency
BETR·CSE·CAD
BETRF·OTC Markets·USD
BETR·CBOE Canada·CAD
Currency in CAD
0.085
0.000(0.00%)
Closed·
BETR Scorecard
Full Analysis
Suffers from weak gross profit margins
BETR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
0.0850.085
52 wk Range
0.0800.175
Key Statistics
Edit
Bid/Ask
0.13 / 0.15
Prev. Close
0.13
Open
0.085
Day's Range
0.085-0.085
52 wk Range
0.08-0.175
Volume
30K
Average Volume (3m)
37.85K
1-Year Change
-41.38%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BETR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 6
Short term obligations exceed liquid assets
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

BetterLife Pharma Inc Company Profile

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat anxiety related disorders, including benzodiazepine dependency. It is also developing MM-001, a topical cream formulation of interferon-alpha 2b, which has completed Phase II clinical trials for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and MM-003, a patent pending proprietary interferon alpha-2b inhalation formulation that has completed Phase II clinical trials for the treatment of COVID-19 and other respiratory viral infections. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
7
Market
Canada

Compare BETR to Peers and Sector

Metrics to compare
BETR
Peers
Sector
Relationship
P/E Ratio
0.0x−2.3x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x1.5x2.6x
Price / LTM Sales
0.0x0.8x3.2x
Upside (Analyst Target)
0.0%39.1%38.8%
Fair Value Upside
Unlock18.8%5.4%Unlock

Earnings

Latest Release
Jun 27, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

BETR Income Statement

FAQ

What Stock Exchange Does BetterLife Pharma Inc Trade On?

BetterLife Pharma Inc is listed and trades on the Canadian Securities Exchange stock exchange.

What Is the Stock Symbol for BetterLife Pharma Inc?

The stock symbol for BetterLife Pharma Inc is "BETR."

What Is the BetterLife Pharma Inc Market Cap?

As of today, BetterLife Pharma Inc market cap is 13.61M.

What Is BetterLife Pharma Inc's Earnings Per Share (TTM)?

The BetterLife Pharma Inc EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is BETR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BetterLife Pharma Inc Stock Split?

BetterLife Pharma Inc has split 2 times.

How Many Employees Does BetterLife Pharma Inc Have?

BetterLife Pharma Inc has 7 employees.

What is the current trading status of BetterLife Pharma Inc (BETR)?

As of 31 Aug 2025, BetterLife Pharma Inc (BETR) is trading at a price of 0.085, with a previous close of 0.13. The stock has fluctuated within a day range of 0.085 to 0.085, while its 52-week range spans from 0.080 to 0.175.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.